Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1

por Bokhari, Amber A., Lee, Laura R., Raboteau, Dewayne, Turbov, Jane, Rodriguez, Isabel V., Pike, John Wesley, Hamilton, Chad A., Maxwell, George Larry, Rodriguez, Gustavo C., Syed, Viqar
Publicado 2016

Jupiter microtubule‐associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers

por Bateman, Nicholas W., Teng, Pang‐Ning, Hope, Erica, Hood, Brian L., Oliver, Julie, Ao, Wei, Zhou, Ming, Wang, Guisong, Tommarello, Domenic, Wilson, Katlin, Litzy, Tracy, Conrads, Kelly A., Hamilton, Chad A., Darcy, Kathleen M., Casablanca, Yovanni, Maxwell, George Larry, Bae‐Jump, Victoria, Conrads, Thomas P.
Publicado 2019

Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study

por Casablanca, Yovanni, Wang, Guisong, Lankes, Heather A., Tian, Chunqiao, Bateman, Nicholas W., Miller, Caela R., Chappell, Nicole P., Havrilesky, Laura J., Wallace, Amy Hooks, Ramirez, Nilsa C., Miller, David S., Oliver, Julie, Mitchell, Dave, Litzi, Tracy, Blanton, Brian E., Lowery, William J., Risinger, John I., Hamilton, Chad A., Phippen, Neil T., Conrads, Thomas P., Mutch, David, Moxley, Katherine, Lee, Roger B., Backes, Floor, Birrer, Michael J., Darcy, Kathleen M., Maxwell, George Larry
Publicado 2022